Can-Fite BioPharma (CANF) Return on Equity [ROE] (2015 - 2023)
Can-Fite BioPharma's Return on Equity [ROE] was -178.24% in FY2025, down 43.29 percentage points from -134.94% in FY2024.
Powered by 
Analysis
Can-Fite BioPharma (CANF) Return on Equity [ROE] (2015 - 2023) Analysis & Trends
From FY2016 onward, Can-Fite BioPharma has reported Return on Equity [ROE] for 10 years.
- Return on Equity [ROE] shows a five-year change of +160.96 percentage points (FY2020 to FY2025).
- The FY2025 figure marks the lowest annual Return on Equity [ROE] since FY2020.
- Per Business Quant data, Return on Equity [ROE] in earlier years was -134.94% in FY2024 (+7.55 pp), -142.49% in FY2023 (-61.51 pp), -80.98% in FY2022 (+42.36 pp) and -123.34% in FY2021 (+215.86 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Can-Fite BioPharma | 1.79 Mn | -17.91 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -137.83% |
| Sep 30, 2023 | -111.29% |
| Jun 30, 2023 | -97.68% |
| Mar 31, 2023 | -122.05% |
| Dec 31, 2022 | -128.30% |
| Sep 30, 2022 | -130.16% |
| Jun 30, 2022 | -110.81% |
| Mar 31, 2022 | -99.76% |
| Dec 31, 2021 | -106.38% |
| Sep 30, 2021 | -182.56% |
| Jun 30, 2021 | -204.93% |
| Mar 31, 2021 | -182.16% |
| Dec 31, 2020 | -190.65% |
| Sep 30, 2020 | -151.90% |
| Jun 30, 2020 | -316.43% |
| Dec 31, 2019 | -265.85% |
| Sep 30, 2019 | -145.45% |
| Dec 31, 2018 | -139.78% |
| Sep 30, 2018 | -197.01% |
| Jun 30, 2018 | -232.13% |
API Access
Can-Fite BioPharma Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CANF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "CANF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CANF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();